Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.6516 | 27 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.51408 | 22 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.52451 | 22 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.46748 | 22 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.46422 | 22 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.58078 | 22 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.57344 | 23 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.52086 | 23 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.48714 | 22 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.61613 | 27 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.51193 | 22 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.52185 | 24 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.50435 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.50773 | 22 |